Skip to main content
. 2020 Nov 26;10(4):244. doi: 10.3390/jpm10040244

Figure 3.

Figure 3

Gene content of the different targeted panels. (A) Approach of the different panels to assess the main genetic alterations in BCP-ALL. (B) Overlapping gene content in the different Next Generation Sequencing-targeted compared panels. (C) Overlapping fusion content in the OncomineTM Childhood Research Assay and Archer® FusionPlex® ALL kit.